Guangzhou Improve Med Instrument (300030) — Strategic Asset Allocation Index
Guangzhou Improve Med Instrument (300030) has a Strategic Asset Allocation Index of 47.0% as of June 2023. Strategic assets (PP&E of CN¥391.14 Million plus long-term investments of CN¥-) total CN¥391.14 Million, measured against net assets of CN¥832.17 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See how leveraged is Guangzhou Improve Med Instrument's balance sheet to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Guangzhou Improve Med Instrument Strategic Asset Allocation Index (2006–2022)
This chart shows how Guangzhou Improve Med Instrument's Strategic Asset Allocation Index has evolved across 17 annual periods from 2006 to 2022. As of June 2023, the index stands at 47.0%, representing strategic assets of CN¥391.14 Million against net assets of CN¥832.17 Million CNY. For live market cap and overall valuation, see 300030 company net worth.
Annual Strategic Asset Allocation Index for Guangzhou Improve Med Instrument (2006–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Guangzhou Improve Med Instrument from 2006 to 2022, covering 17 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Guangzhou Improve Med Instrument book value and equity for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 49.6% | CN¥407.12 Million | CN¥407.12 Million | CN¥- | CN¥820.61 Million | ▲ +10.0 pp |
| 2021 | 39.6% | CN¥408.54 Million | CN¥408.54 Million | CN¥- | CN¥1.03 Billion | ▲ +5.0 pp |
| 2020 | 34.6% | CN¥347.45 Million | CN¥347.45 Million | CN¥- | CN¥1.00 Billion | ▼ -25.2 pp |
| 2019 | 59.9% | CN¥501.93 Million | CN¥305.29 Million | CN¥196.64 Million | CN¥838.26 Million | ▲ +0.3 pp |
| 2018 | 59.6% | CN¥485.70 Million | CN¥308.90 Million | CN¥176.80 Million | CN¥815.47 Million | ▲ +7.9 pp |
| 2017 | 51.7% | CN¥498.11 Million | CN¥321.51 Million | CN¥176.60 Million | CN¥963.72 Million | ▲ +0.7 pp |
| 2016 | 51.0% | CN¥486.58 Million | CN¥312.97 Million | CN¥173.60 Million | CN¥954.18 Million | ▲ +0.0 pp |
| 2015 | 50.9% | CN¥474.04 Million | CN¥316.12 Million | CN¥157.92 Million | CN¥930.46 Million | ▲ +15.0 pp |
| 2014 | 36.0% | CN¥281.32 Million | CN¥281.32 Million | CN¥- | CN¥782.00 Million | ▲ +6.2 pp |
| 2013 | 29.8% | CN¥230.37 Million | CN¥230.37 Million | CN¥- | CN¥772.70 Million | ▼ -2.1 pp |
| 2012 | 31.9% | CN¥219.68 Million | CN¥219.68 Million | CN¥- | CN¥687.93 Million | ▲ +0.5 pp |
| 2011 | 31.4% | CN¥203.84 Million | CN¥203.84 Million | CN¥- | CN¥648.25 Million | ▲ +6.4 pp |
| 2010 | 25.1% | CN¥148.61 Million | CN¥148.61 Million | CN¥- | CN¥592.55 Million | ▲ +7.9 pp |
| 2009 | 17.2% | CN¥97.00 Million | CN¥97.00 Million | CN¥- | CN¥563.53 Million | ▼ -44.4 pp |
| 2008 | 61.6% | CN¥48.49 Million | CN¥48.49 Million | CN¥- | CN¥78.73 Million | ▲ +46.4 pp |
| 2007 | 15.1% | CN¥8.83 Million | CN¥8.83 Million | CN¥- | CN¥58.27 Million | ▼ -13.9 pp |
| 2006 | 29.1% | CN¥5.62 Million | CN¥5.62 Million | CN¥- | CN¥19.33 Million | — |